- CytoDyn to Present at Singular Summer Solstice 2018 Conference on July 19
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2018 Financial Results
- Nohla Therapeutics Receives FDA Orphan Drug Designation for Dilanubicel for Hematopoietic Stem Cell Transplant Patients
- Diamond Equity Research Initiates Coverage on AquaBounty Technologies Inc. (NASDAQ: AQB) with a Valuation of $4.25 Per Share
- CytoDyn Announces Positive Results from Completed Pivotal PRO 140 HIV Combination Trial
- CytoDyn to Hold Investment Community Conference Call on July 17, 2018
- BASF to donate $7 million toward construction of new UC Berkeley research chemistry facility
- CytoDyn to Expand Strategic Focus with PRO 140 to Cancer and Immunologic Disorders
- Cytokinetics to Announce Second Quarter Results on July 26, 2018
- ProQR Announces Presentations on Programs in Ophthalmology at Conferences in July
